Prefilled Syringe

Supporting Improved Patient Onboarding and Adherence With Training Solutions

By Bill Guilliouma | May 28, 2020
Posted in , , , , , , , , , , , , , ,

With more biologics and drug delivery device options entering the market in recent years, pharma companies can decide whether it would be easier for patients to self-inject with an autoinjector… Read More »

Response to News Release from 215 Biopharma KOLs

By Bill Guilliouma | January 14, 2020
Posted in , , , , , , , , , ,

In the January 2020 edition of STAT News was a news release from 215 biopharma CEOs and industry leaders. The news release leverages 2020 as the beginning of “the dawn… Read More »

How Well Are Your Rheumatology Patients Self-Administering Their Medication?

By Bill Guilliouma | October 9, 2019
Posted in , , , , , , , ,

  A primary goal of rheumatologists remains alleviating the pain, stiffness and tenderness that mark rheumatoid arthritis (RA). Yet in an era marked by a significant increase in self-injection options,… Read More »

DermWireTV: Noble Educates on Self-Injection

By Bill Guilliouma | August 1, 2019
Posted in , , , , , , , , , ,

Participants in a study by the company Noble show that the vast majority of patients—92%—would prefer to bring home a training device to practice with prior to starting self-injection. Noble creates… Read More »

Training Diabetes Patients on Self-Injection Is Essential

By ThriveAdmin | May 16, 2019
Posted in , , , , , , , , ,

Ensuring that diabetes patients correctly administer their insulin or glucagon is a priority for prescribers and patients alike. Keeping tabs on the extent to which patients are (or are not)… Read More »

Gaps in Training, Poor Adherence Highlight Need For Dermatologists To Demand Improved Onboarding Tools

By ThriveAdmin | May 10, 2019
Posted in , , , , , , , , ,

Desperate for relief, many people living with psoriasis and atopic dermatitis rely on biologic therapies that require users to self-inject. Because self-injecting can be a daunting task—evidenced by the 45%… Read More »